Xiubin Liang

2.0k citations
62 papers · 1.5k indexed · h-index 22
Topics
Ion Transport and Channel Regulation (8 papers)Cystic Fibrosis Research Advances (7 papers)S100 Proteins and Annexins (7 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xiubin Liang

60 papers receiving 1.5k citations

Peers

Xiubin Liang
Comparison fields: 5 of 101
  • Molecular Biology 855
  • Nephrology 268
  • Cancer Research 255
  • Epidemiology 245
  • Cell Biology 177
Replace Xuejing Zhu with:
Xuejing Zhu China
Jun Hao China
Zhigang Zhang China
Mi Ra Yu South Korea
Samy L. Habib United States
Honglian Wang China
Seiji Inoshita Japan
Min Zhao China
Miguel Arévalo Spain
Hui Lin China
Xiubin Liang relative to Xuejing Zhu China Xuejing Zhu's profile →
Citations per field
00.5×
Xuejing Zhu · 1×
Citations per year

Countries citing papers authored by Xiubin Liang

Since Specialization
Citations

This map shows the geographic impact of Xiubin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiubin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiubin Liang more than expected).

Fields of papers citing papers by Xiubin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiubin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiubin Liang. The network helps show where Xiubin Liang may publish in the future.

Co-authorship network of co-authors of Xiubin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiubin Liang. A scholar is included among the top collaborators of Xiubin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiubin Liang. Xiubin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 4
3 1
4 2
5 2
6 13
7 1
8 5
9 16
10 50
11 18
12 16
13 41
14 19
15 92
16 22
17 53
18 52
19 38
20 95

About Xiubin Liang

Xiubin Liang is a scholar working on Nephrology, Cancer Research and Molecular Biology, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (8 papers), Cystic Fibrosis Research Advances (7 papers) and S100 Proteins and Annexins (7 papers). The work is most often cited by research in Nephrology (268 citations), Cancer Research (255 citations) and Molecular Biology (855 citations). Xiubin Liang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Dongming Su, Michael Butterworth, Raymond A. Frizzell, Kathryn W. Peters, Dongming Su, Agnes B. Fogo, Min Li, Yachen Shen, Yifei Sun and Hangyu Li. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026